In addition, studies in vitro have shown that TWEAK-triggered Fn14 activation in cancer cells themselves can stimulate both “protumorigenic/metastatic” and “anti-tumorigenic/metastatic” cellular responses, depending on the investigated cell lines. This evidence concerns the gene TNFRSF12A and cancer.